Article
Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients
28 Jan 2015
Abstract excerpt
BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is an aggressive disease, with 30% to 40% of patients failing to be cured with available primary therapy. microRNAs (miRNAs) are RNA molecules that attenuate expression of their mRNA targets. To characterize the DLBCL miRNome, we sequenced miRNAs from 92 DLBCL and 15 benign centroblast fresh frozen samples and from 140 DLBCL formalin-fixed, paraffin-embedded...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
